C108 has clear splenic cDC1 phenotype, high CD24 and XCR1, and relatively high CD86, and has clearly distinct group-wise effects: enriched after exposure to maternal schistosomiasis, but relatively reduced after exposure to treatment. This evidence concerns the gene XCR1 and schistosomiasis.